secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q/C TECHNOLOGIES, INC. (QCLS)
CIK:        0001321834
Form:       8-K
Filed at:   2025-03-10T23:59:59+00:00
Accession:  0001493152-25-009717
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TNF Pharmaceuticals holds investor call on Isomyosamine R&D progress
--------------------------------------------------------------------

- Conference call conducted March 6, 2025 to discuss research and development of lead compound Isomyosamine.
- Transcript furnished as Exhibit 10.1; no specific clinical or financial data provided in the available text.
- Company noted it undertakes no obligation to update the materials.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321834/000149315225009717/0001493152-25-009717-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321834/000149315225009717/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-009717

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer